1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Norman FF, Chen LH.

    Travel-associated melioidosis: a narrative review

    JOURNAL OF TRAVEL MEDICINE . 30(3): .

    [doi:10.1093/jtm/taad039]

  • Castillo-Mancilla JR, Morrow M, Hunt PW, Schnittman SR, Phillips AN, Baker JV, Haberer JE, Janeiro MJ, Aragao F, Cohen C, Musinguzi N, Brown TT, Cavassini M, Glass TR, Serrano-Villar S, Mawhinney S, Siedner M.

    Beyond Undetectable: Modeling the Clinical Benefit of Improved Antiretroviral Adherence in Persons With Human Immunodeficiency Virus With Virologic Suppression

    Open forum infectious diseases . 10(5): . Nº de citas: 2

    [doi:10.1093/ofid/ofad230]

  • Casado JL, Vizcarra P, Martín-Colmenarejo S, Del Pino J, Gomez-Maldonado S, Martín-Hondarza A, Vallejo A.

    Lower T cell response against SARS-CoV-2 variants of concern after mRNA vaccine and risk of breakthrough infections in people living with HIV.

    AIDS . 37(6): 877-882. Nº de citas: 1

    [doi:10.1097/QAD.0000000000003504]

  • Simon F, Caumes E, Jelinek T, Lopez-Velez R, Steffen R, Chen LH.

    Chikungunya: risks for travellers

    JOURNAL OF TRAVEL MEDICINE . 30(2): . Nº de citas: 3

    [doi:10.1093/jtm/taad008]

  • Suárez-García I, Alejos B, Hernando V, Viñuela L, Vera García M, Rial-Crestelo D, Pérez Elías MJ, Albendín Iglesias H, Peraire J, Tiraboschi J, Díaz A, Moreno S, Jarrín I.

    Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . : . Nº de citas: 1

    [doi:10.1093/jac/dkad102]

  • Saavedra C, Vallejo A, Longo F, Serrano JJ, Fernández M, Gion M, López-Miranda E, Martínez-Jáñez N, Guerra E, Chamorro J, Rosero D, Velasco H, Martín A, Carrato A, Casado JL, Cortés A.

    Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors

    Cancers . 15(7): . Nº de citas: 1

    [doi:10.3390/cancers15072000]

  • Kolossváry M, deFilippi C, McCallum S, Fitch KV, Diggs MR, Fulda ES, Ribaudo HJ, Fichtenbaum CJ, Aberg JA, Malvestutto CD, Currier JS, Casado JL, Gutiérrez F, Sereti I, Douglas PS, Zanni MV, Grinspoon SK.

    Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV.

    EBioMedicine . 90: 104538-104538.

    [doi:10.1016/j.ebiom.2023.104538]

  • Martín Sánchez FJ, Martínez-Sellés M, Molero García JM, Moreno Guillén S, Rodríguez-Artalejo FJ, Ruiz-Galiana J, Cantón R, De Lucas Ramos P, García-Botella A, García-Lledó A, Hernández-Sampelayo T, Gómez-Pavón J, González Del Castillo J, Martín-Delgado MC, Bouza E.

    Insights for COVID-19 in 2023.

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 36(2): 114-124. Nº de citas: 4

    [doi:10.37201/req/122.2022]

  • Pérez Molina JA, Crespillo-Andújar C, Zamora J, Fernández-Félix BM, Gaetano-Gil A, López-Bernaldo de Quirós JC, Serrano-Villar S, Moreno S, Álvarez-Díaz N, Berenguer J.

    Contribution of low CD4 cell counts and high HIV viral load to the efficacy of preferred first-line antiretroviral regimens for treating HIV infection: A systematic review and meta-analysis.

    CLINICAL INFECTIOUS DISEASES . 76(11): 2027-2037.

    [doi:10.1093/cid/ciad177]

  • Ron R, Moreno E, Martínez-Sanz J, Brañas F, Sainz T, Moreno S, Serrano-Villar S.

    CD4/CD8 ratio during HIV treatment: time for routine monitoring?

    CLINICAL INFECTIOUS DISEASES . 76(9): 1688-1696. Nº de citas: 1

    [doi:10.1093/cid/ciad136]

  • Úbeda M, Maza MDC, Delgado P, Horndler L, Abia D, García-Bermejo L, Serrano-Villar S, Calvo C, Bastolla U, Sainz T, Fresno M.

    Diversity of immune responses in children highly exposed to SARS-CoV-2.

    Frontiers in immunology . 14: 1105237-1105237.

    [doi:10.3389/fimmu.2023.1105237]

  • Escudero-Sánchez R, Rubio Martín E, Vizcarra P, Braojos Sánchez F, Diaz Gago Á, Del Campo Albendea L, Muriel A, Halperin A, Ponce Alonso M, Moreno Guillén S, Cobo J.

    Conventional versus extended-pulsed fidaxomicin dosing in patients at high risk of recurrence of Clostridioides difficile infection: a propensity score analysis.

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 78(3): 823-827.

    [doi:10.1093/jac/dkad019]

  • Schnittman SR, Kitch DW, Swartz TH, Burdo TH, Fitch KV, McCallum S, Flynn JM, Fulda ES, Diggs MR, Stapleton JT, Casado JL, Taron J, Currier JS, Zanni MV, Malvestutto C, Fichtenbaum CJ, Aberg JA, Ribaudo HJ, Lu MT, Douglas PS, Grinspoon SK.

    Coronary Artery Plaque Composition and Severity Relate to the Inflammasome in People With Treated Human Immunodeficiency Virus.

    Open forum infectious diseases . 10(3): .

    [doi:10.1093/ofid/ofad106]

  • Núñez-Pereira S, Benavent E, Ulldemolins M, Sobrino-Díaz B, Iribarren JA, Escudero-Sánchez R, Del Toro MD, Nodar A, Sorli L, Bahamonde A, Vilchez HH, Gasch O, Muñez E, Rodríguez-Montserrat D, García-País MJ, Haddad S, Sellarès-Nadal J, Murillo O, Rodríguez-Pardo D, On Behalf Of Geio-Seimc Group For The Study Of Osteoarticular Infections-Spanish.

    Cutibacterium spp. Infections after Instrumented Spine Surgery Have a Good Prognosis Regardless of Rifampin Use: A Cross-Sectional Study

    ANTIBIOTICS-BASEL . 12(3): .

    [doi:10.3390/antibiotics12030518]

  • Pérez-Galera S, Bravo-Ferrer JM, Paniagua M, Kostyanev T, de Kraker MEA, Feifel J, Sojo-Dorado J, Schotsman J, Cantón R, Daikos GL, Carevic B, Dragovac G, Tan LK, Raka L, Hristea A, Viale P, Akova M, Reguera JM, Valiente de Santis L, Torre-Cisneros J, Cano Á, Roilides E, Radulovic L, Kirakli C, Shaw E, Falagas ME, Pintado V, Goossens H, Bonten MJ, Gutiérrez-Gutiérrez B, Rodriguez-Baño J.

    Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control- control study (EURECA)

    Eclinicalmedicine . 57: 101871-101871. Nº de citas: 8

    [doi:10.1016/j.eclinm.2023.101871]

  • Fernández-Ruiz M, Bodro M, Gutiérrez Martín I, Rodriguez-Álvarez R, Ruiz-Ruigómez M, Sabé N, López-Viñau T, Valerio M, Illaro A, Fortún J, Salto-Alejandre S, Cordero E, Fariñas MDC, Muñoz P, Vidal E, Carratalà J, Goikoetxea J, Ramos-Martínez A, Moreno A, Aguado JM.

    Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice

    Transplantation . 107(3): 762-773. Nº de citas: 3

    [doi:10.1097/TP.0000000000004312]

  • Casado JL, Vizcarra P, Martín-Hondarza A, Blasco M, Grandal-Platero M, Haemmerle J, Fernández-Escribano M, Vallejo A.

    Impact of Previous Common Human Coronavirus Exposure on SARS-CoV-2-Specific T-Cell and Memory B-Cell Response after mRNA-Based Vaccination.

    VIRUSES-BASEL . 15(3): . Nº de citas: 1

    [doi:10.3390/v15030627]

  • de Gea-Grela A, Moreno S.

    Controversies in the Design of Strategies for the Cure of HIV Infection.

    PATHOGENS . 12(2): . Nº de citas: 1

    [doi:10.3390/pathogens12020322]